Rare but severe liver side-effects reported among South African patients starting efavirenz-based ART - aidsmap
Rare but severe liver side-effects reported among South African patients starting efavirenz-based ARTaidsmapTreatment with efavirenz has been associated with rare but severe liver complications among patients receiving antiretroviral therapy (ART) in South Africa.
Strides Shasun up 2% on USFDA approval for Efavirenz tablets - Moneycontrol.com
Strides Shasun receives tentative nod from USFDA for HIV drug Efavirenz - Jagran Josh
Strides Shasun receives tentative nod from USFDA for HIV drug EfavirenzJagran JoshStrides Shasun on 26 May 2016 announced that it has received tentative approval from the U.
Why reticent HIV patients in Ahmednagar are braving stigma to organise street protests - Scroll.in
Sustiva-based ART may cause severe liver injury - Healio
Sustiva-based ART may cause severe liver injuryHealioSustiva (efavirenz, Bristol-Myers Squibb) became a first-line regimen in antiretroviral therapy (ART) through use of a fixed-dose combination with Viread (tenofovir, Gilead Sciences) and Emtriva (emtricitabine, Gilead Sciences), since changes to .